Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Status:
Completed
Trial end date:
2017-03-17
Target enrollment:
Participant gender:
Summary
This is an open-label exploratory study of CTAP101 Capsules in patients with bone metastases
arising from either breast or prostate cancer, who are taking anti-resorptive therapy.
Phase:
Phase 1
Details
Lead Sponsor:
OPKO Health, Inc. OPKO Ireland Global Holdings Ltd.